Article

NASA Astronauts get superior and safer LASIK

Santa Ana, CA-Advanced Medical Optics (AMO) received approval from the National Aeronautics and Space Agency (NASA) today to use the company's LASIK technologies on United States Astronauts.

Santa Ana, CA-Advanced Medical Optics (AMO) received approval from the National Aeronautics and Space Agency (NASA) today to use the company's LASIK technologies on United States Astronauts.

Consumers received approval a decade ago however, NASA didn't approve it for missions until it was developed into an all laser procedure. AMO's LASIK with InterLase Method has permission from NASA for use on pilots, mission and payload specialists who face extreme conditions in space.

"NASA's approval is further evidence that today's LASIK exceeds all established standards of safety and effectiveness," said Steven Schallhorn, M.D., retired captain of the U.S. Navy.

The InterLase (femtosecond) laser replaces the hand-held micrkeratome blade used for creating LASIK corneal flaps. The laser eliminates almost all of the sight threatening LASIK complications related to microkeratomes.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.